Integrated approach to weight management combines medication with nutritional guidance, lifestyle coaching, and support for sustainable results
For example, curcumin has been evaluated in Phase II clinical studies in pancreatic cancer and colorectal cancer patients, where oral doses up to 8 g/day demonstrated acceptable safety but limited systemic exposure, highlighting pharmacokinetic challenges
Metabolite profiling reveals the glutathione biosynthetic pathway as a therapeutic target in triple-negative breast cancer
The TRANSCEND-T2D-1 trial demonstrated A1C reductions of up to 2.0% and weight loss of up to 16.8% at 40 weeks, with no plateau observed through the end of the treatment period
The rise of GLP-1 is creating a new consumer segment that deserves attention beyond the healthcare industry, said Gupta
[28] [29] L-carnitine is used as a supplement for people with chronic heart disease and has been shown to reduce blood pressure by 10 points